Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


J&J Picks Up Listerine, Nicorette With $16.6 Bil. Purchase Of Pfizer OTCs

This article was originally published in The Tan Sheet

Executive Summary

Johnson & Johnson's successful bid to acquire Pfizer Consumer Healthcare extends the firm's reach in the global OTC market and provides entry into several new product categories

Related Content

Employers Could Be Hot Target For OTC Smoking-Cessation Sales – Survey
J&J, Pfizer Satisfy FTC Conditions To Clear Deal; EC Signs Off
EC eyes J&J-Pfizer
Sales & Earnings In Brief
Boehringer Hits Above The Belt With Zantac Purchase
Chattem Acquires “Great Brands” In Wake Of J&J’s Pfizer Purchase
Rogaine Foam Patents To Keep Product Covered Through 2019, Pfizer Says
Listerine, MD?
J&J Envisions Eye Care, Oral Care Expansions Following Pfizer OTC Purchase
Rembrandt Purchase Brings Whitening Category To J&J





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts